Clinical trials
Color Vision Defects trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pakistan Institute of Living and Learning | 3 |
| University Hospital Tuebingen | 2 |
| 113 Suicide Prevention | 1 |
| Anglia Ruskin University | 1 |
| Central Institute of Mental Health, Mannheim | 1 |
| Emory University | 1 |
| Karlstad University | 1 |
| Karolinska Institutet | 1 |
| Limbic Limited | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Color Vision Defects | 26 |
| Psychotic Disorders | 3 |
| Chronic Pain | 2 |
| Alzheimer Disease | 1 |
| Anxiety Disorders | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Bipolar Disorder | 1 |
| Cancer Pain | 1 |
| Dental Caries | 1 |
| Dyspareunia | 1 |
Trials
Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.